company background image
5432

Heranba Industries BSE:543266 Stock Report

Last Price

₹564.35

Market Cap

₹22.6b

7D

-1.9%

1Y

-29.7%

Updated

16 Aug, 2022

Data

Company Financials
543266 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends2/6

543266 Stock Overview

Heranba Industries Limited manufactures, markets, and sells a range of agrochemicals in India.

Heranba Industries Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Heranba Industries
Historical stock prices
Current Share Price₹564.35
52 Week High₹836.45
52 Week Low₹505.55
Beta0
1 Month Change-3.12%
3 Month Change0.97%
1 Year Change-29.72%
3 Year Changen/a
5 Year Changen/a
Change since IPO-30.52%

Recent News & Updates

Shareholder Returns

543266IN ChemicalsIN Market
7D-1.9%2.0%1.9%
1Y-29.7%11.9%9.1%

Return vs Industry: 543266 underperformed the Indian Chemicals industry which returned 10.6% over the past year.

Return vs Market: 543266 underperformed the Indian Market which returned 8.3% over the past year.

Price Volatility

Is 543266's price volatile compared to industry and market?
543266 volatility
543266 Average Weekly Movement3.5%
Chemicals Industry Average Movement6.3%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 543266 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 543266's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1992714Raghuram Shettyhttps://www.heranba.co.in

Heranba Industries Limited manufactures, markets, and sells a range of agrochemicals in India. The company provides intermediates, such as cypermethric acid chloride, high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and technical products, including cypermethrin, deltamethrin, alpha cypermethrin, acephate, lambda cyhalothrin, bifenthrin, and tranfluthrin, as well as tricyclazole, hexaconazole, tebuconazole, glyphosate, metribuzin, clodinafop, and bispyribac sodium. It also offers formulations comprising emulsifiable concentrate, water dispersible granule, suspension concentrate, capsule suspension, oil dispersion, concentrated aqueous emulsions, suspoemulsion, and zc formulation.

Heranba Industries Limited Fundamentals Summary

How do Heranba Industries's earnings and revenue compare to its market cap?
543266 fundamental statistics
Market Cap₹22.58b
Earnings (TTM)₹1.75b
Revenue (TTM)₹14.61b

12.9x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
543266 income statement (TTM)
Revenue₹14.61b
Cost of Revenue₹9.54b
Gross Profit₹5.07b
Other Expenses₹3.32b
Earnings₹1.75b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)43.76
Gross Margin34.73%
Net Profit Margin11.99%
Debt/Equity Ratio8.5%

How did 543266 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

5%

Payout Ratio